We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Rapid HIV Tests Performed on Minute Blood Samples

By HospiMedica staff writers
Posted on 01 May 2006
New HIV tests detect HIV-1 and HIV-2 antibodies in four different matrices: finger-stick whole blood, venous whole blood, serum, and plasma. More...
Tests are complete within approximately 15 minutes of sample application.

Chembio Diagnostics, Inc. (Medford, NY, USA) has received an "approvable” letter from the U.S. Food and Drug Administration (FDA, Rockville, MD, USA) for its Sure Check HIV 1/2 and HIV 1/2 Stat-Pak rapid test Pre-Market Applications (PMA). Chembio's PMA approval is subject only to final review by the FDA of the products' package inserts and other standard conditions related to all PMAs. Chembio anticipates that the approval will be given very soon allowing the company to market its tests to clinical laboratories and hospitals in the United States.

Easy to perform, the two new rapid tests are highly sensitive and specific. They are safe, requiring as little as 2.5-5.0 µl, which is easily obtained from a finger prick. However, the FDA PMA approval, when granted, will be also for whole blood, serum, and plasma samples. Both products have a built-in internal control (a true IgG), and provide a 24-month shelf life at 8-30º C.

"Estimates are that as much as one-third of those infected with HIV in the US population are not aware of their HIV-Positive status. We believe that that these individuals are much more likely to access testing services if test results and counseling can be delivered at point of care,” said Lawrence Siebert, president and CEO of Chembio. Mr. Siebert continued, "The U.S. is a very important market for Chembio and those that need to be tested, as there are only two competitive products currently approved. Moreover, we believe that PMA approval, when granted, will provide further impetus to our international marketing efforts, including opening markets not currently available.”

Chembio is one of the four recommended global rapid HIV test suppliers under the U.S. Clinton HIV/AIDS initiative. The company has also developed tests for other diseases including human and veterinary tuberculosis, and Chagas disease.



Related Links:
Chembio Diagnostics
Clinton HIV/AIDS initiative

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.